Clinical Trial Update: Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating tigecycline in adult subjects with primary biliary cholangitis (biliary liver cirrhosis). The study status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• TYGACIL (tigecycline)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Liver Cirrhosis, Biliary | Phase 1 | Status: COMPLETED